Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

25. Januar 2005 08:30 ET | Quelle: U.S. BioDefense

U.S. BioDefense Signs Agreement to Evaluate and Option to License Adult Stem Cell Sorting and Enrichment Patent Rights Applications Related to Gene Therapy and Bioengineered Skin Process Now in FDA Proof of Concept Developed in Part by A $1.25 Million Grant From The National Institute of Dental and Craniofacial Research, Part of The National Institutes of Health

CITY OF INDUSTRY, Calif., Jan. 25, 2005 (PRIMEZONE) -- U.S. BioDefense (OTCBB:UBDF) is pleased to announce today that it has signed an option license agreement with a major university and will now...
21. Januar 2005 07:45 ET | Quelle: U.S. BioDefense

U.S. BioDefense to Launch Open Source Platform for Rapid Stem Cell Research and Development

CITY OF INDUSTRY, Calif., Jan. 21, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDF) announced today that it is developing an Open Source Stem Cell Research Platform to leverage the distributed...
18. Januar 2005 09:00 ET | Quelle: U.S. BioDefense

U.S. BioDefense Files 'Stem Cell Technology and Autologous Bioengineered Skin for Medical Countermeasure' Proposal with Department of Defense Chemical Biological Defense Agency

CITY OF INDUSTRY, Calif., Jan. 18, 2005 (PRIMEZONE) -- U.S. BioDefense (OTCBB:UBDF) is pleased to announce that it has met today's deadline to file its Small Business Innovation Research (SBIR) Grant...

Vorherige Seite